TiRobot

Tinavi Medical Technologies is a Chinese medical robotics company. The TiRobot is an orthopedic surgical robot system designed for spine and trauma surgery, guiding surgeons in the accurate placement of pedicle screws and other implants using preoperative CT imaging and real-time intraoperative navigation. The TiRobot received FDA 510(k) clearance for use in the United States and NMPA approval in China.

Yes. TiRobot is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

TiRobot is made by Tinavi Medical Technologies, based in Beijing, China, founded in 2005.

1 verified deployment of TiRobot is on the DEPLOY registry, including at Beijing, China.

TiRobot is at research stage and is not yet available for sale.

TiRobot has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance, cleared. See the Regulatory filings section for each agency source.

On the DEPLOY registry, comparable surgical robots to TiRobot include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

TiRobot and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. TiRobot has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, TiRobot ranks in roughly the top 84% of surgical models tracked by the registry.

TiRobot is at the research stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Research stage means active development without commercial deployments on file.

TiRobot has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.